Period Ending | Dec 31, 2010 | Dec 31, 2009 |
---|
Total Revenue
|
116,744
|
111,943
| Cost of Revenue | 86,013 | 102,408 | |
Gross Profit
|
30,731
|
9,535
| |
|
Operating Expenses |
|
Research Development | 92,996 | 19,282 |
|
Selling General and Administrative | 84,573 | 42,150 |
|
Non Recurring |
-
|
-
|
|
Others |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
(146,838)
|
(51,897)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (6,325) | (1,286) |
|
Earnings Before Interest And Taxes | (153,163) | (53,183) |
|
Interest Expense | 992 | 2,531 |
|
Income Before Tax | (154,155) | (55,714) |
|
Income Tax Expense | 173 | 26 |
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | (154,328) | (55,740) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
(154,328)
|
(55,740)
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
(154,328)
|
(55,740)
|
|